Organic sales increased by 2%, with varying performance across segments. Health Care, Grooming, and Fabric & Home Care showed organic sales growth, while Baby, Feminine & Family Care experienced a decline. This suggests a targeted growth strategy focused on specific product categories and geographies.

The company incurred restructuring charges of $0.8 billion after tax related to the substantial liquidation of operations in certain Enterprise Markets, including Argentina. This indicates a strategic shift away from underperforming markets to optimize resource allocation.

The company expects to reduce outstanding shares through direct share repurchases at a value of $6 to $7 billion in fiscal year 2025. This indicates management's confidence in the company's financial health and future cash flow generation.

SG&A spending decreased by 1% due to higher foreign exchange transactional charges in the prior year period and decreased overhead costs. Productivity-driven cost savings delivered 100 basis points of benefit to SG&A as a percentage of net sales.

The amount due to suppliers participating in the Supply Chain Finance program and included in Accounts payable was approximately $5.6 billion as of March 31, 2025. This highlights management's ongoing efforts to optimize payment terms with suppliers.

Days inventory on hand increased by four days driven by higher inventory for new product initiatives and increased safety stock levels. This suggests potential inefficiencies in inventory management or strategic decisions to increase stock for specific reasons.

The Gillette indefinite-lived intangible asset's fair value exceeds its carrying value by greater than 10%. Adverse changes in the business or in the macroeconomic environment, including foreign currency devaluation, increasing global inflation, or market contraction from an economic recession, could reduce the underlying cash flows used to estimate the fair value of the Gillette indefinite-lived intangible asset and trigger a further impairment charge.

The company has significant exposure to exchange rate fluctuations, which have negatively impacted net sales, net earnings, and cash flows. Devaluation of foreign currencies and lags in implementing price increases can further exacerbate these impacts.

The company's costs are subject to fluctuations due to changes in commodity and input material prices, transportation costs, and inflationary impacts. Disruptions in manufacturing, supply and distribution operations can lead to increased costs and negatively impact net sales, net earnings, and cash flows.

Global market share performance varied across segments, with some segments like Health Care gaining share while others like Beauty and Fabric Care experienced declines. This indicates varying competitive pressures and effectiveness of strategies across different product categories.

The company notes competitive activity impacting volume in Latin America and pricing in several regions. This highlights the need for ongoing monitoring and adaptation to competitive pressures to maintain market position.

The company competes against other branded products as well as retailers' private-label brands. This suggests a continuous need to differentiate products and maintain brand loyalty to counter private label competition.

Manufacturing productivity savings of 160 basis points partially offset higher commodity costs and other cost pressures, demonstrating ongoing efforts to improve operational efficiency.

SG&A as a percentage of net sales decreased 120 basis points to 27.9% due to decreases in marketing spending and overhead costs as a percentage of net sales. Productivity-driven cost savings delivered 120 basis points of benefit to SG&A as a percentage of net sales.

The company has historically incurred an ongoing annual level of restructuring-type activities to maintain a competitive cost structure, including manufacturing and workforce optimization. This indicates a continued focus on improving operational efficiency through restructuring initiatives.

Innovation is cited as a driver of volume growth in several segments, including Personal Care in North America and Europe, and Health Care in IMEA. This highlights the importance of ongoing investment in R&D and new product development.

The company acknowledges the need to successfully respond to changing consumer habits and evolving digital marketing and selling platform requirements. This indicates a focus on adapting to technological changes in the market.

The company highlights the ability to rely on and maintain key company and third-party information and operational technology systems, networks and services and maintain the security and functionality of such. This emphasizes the importance of technology infrastructure and cybersecurity.

The company expects to reduce outstanding shares through direct share repurchases at a value of $6 to $7 billion in fiscal year 2025, demonstrating a commitment to returning capital to shareholders.

Financing activities used $10.4 billion of net cash fiscal year to date, mainly due to dividends to shareholders and treasury stock purchases, partially offset by the impact of stock options and other and a net debt increase. This highlights the importance of dividends in the company's capital allocation strategy.

Adjusted free cash flow represents the cash that the Company is able to generate after taking into account planned maintenance and asset expansion. We view adjusted free cash flow as an important measure because it is one factor used in determining the amount of cash available for dividends, share repurchases, acquisitions and other discretionary investments.

The company highlights the ability to successfully achieve our ambition of reducing our greenhouse gas emissions and delivering progress towards our environmental sustainability priorities. This indicates a focus on environmental responsibility.

The company highlights the ability to protect our reputation and brand equity by successfully managing real or perceived issues, including concerns about safety, quality, ingredients, efficacy, packaging content, supply chain practices or similar matters that may arise. This indicates a focus on product safety and responsible supply chain management.

The company highlights the ability to successfully manage the demand, supply and operational challenges, as well as governmental responses or mandates, associated with a disease outbreak, including epidemics, pandemics or similar widespread public health concerns. This indicates a focus on employee health and safety.

The company is exposed to global macroeconomic factors, geopolitical tensions, and government policies. These risks can negatively impact net sales, net earnings, and cash flows. The ongoing war between Russia and Ukraine is also mentioned as a specific concern.

The company is exposed to changes in U.S. and foreign government legislative, regulatory, or enforcement policies that can have a negative impact on net sales, net earnings and cash flows. These include tax policy changes and government controls.

Addressing the Challenges of the Digitalization of the Economy. Government controls such as currency exchanges, pricing and import authorizations as well as government policies related to environmental and climate change matters and changes to international trade agreements, including tariffs, can also impact our financial performance.